Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 4/20 | 0.96 |
| ▸ | MMP8 | P22894 | 3/20 | 0.96 |
| ▸ | MMP14 | P50281 | 2/20 | 0.96 |
| ▸ | MMP1 | P03956 | 1/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tiludronic Acid SCHEMBL8607914 | 0.98 | MMP2 (0.92) | MMP2MMP8MMP14MMP1HSD17B10 | |
| Tiludronic Acid SCHEMBL18988 | 0.98 | MMP2 (1.00) | MMP2MMP8MMP14MMP1HSD17B10 | |
| Tiludronic Acid SCHEMBL2067280 | 0.88 | MMP2 (0.80) | MMP2MMP8MMP14MMP1HSD17B10 | |
| SCHEMBL17954020 | 0.87 | MMP2 (0.79) | MMP2MMP8MMP14MMP1HSD17B10 | |
| Tiludronic Acid SCHEMBL7159094 | 0.85 | MMP2 (0.77) | MMP2MMP8MMP14MMP1HSD17B10 | |
| Tiludronic Acid SCHEMBL2326547 | 0.85 | MMP2 (0.75) | MMP2MMP8MMP14MMP1HSD17B10 | |
| Tiludronic Acid SCHEMBL2323298 | 0.85 | MMP2 (0.75) | MMP2MMP8MMP14MMP1HSD17B10 | |
| Tiludronic Acid SCHEMBL8607912 | 0.84 | MMP2 (0.74) | MMP2MMP8MMP14MMP1HSD17B10 | |
| Tiludronic Acid SCHEMBL41053 | 0.81 | MMP1 (1.00) | MMP2MMP8MMP14MMP1HSD17B10 | |
| SCHEMBL2150897 | 0.80 | MMP2 (0.63) | MMP2MMP8MMP14MMP1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106668067-A | Antitumor combined medicine | 暨南大学 | 2017-05-17 | — | — | CN | claimed |
| CN-206120771-U | Medicine formulation | 南京三迭纪医药科技有限公司 | 2017-04-26 | — | — | CN | disclosed |
| CN-206120770-U | Medicine formulation | 南京三迭纪医药科技有限公司 | 2017-04-26 | — | — | CN | disclosed |
| CN-106236715-A | Pharmaceutical dosage forms and uses thereof | 南京三迭纪医药科技有限公司 | 2016-12-21 | — | — | CN | disclosed |
| CN-103958513-B | Hypoxanthine derivant hydrochloric acid salt | ONO PHARMACEUTICAL CO.,LTD. (JP) | 2015-12-23 | — | — | CN | disclosed |
| CN-103097353-B | Immunomodulator and anti-inflammatory compound | INCOZEN THERAPEUTICS PVT LTD | 2015-03-04 | — | — | CN | disclosed |
| CN-103958513-A | 6-Hydroxypurine derivative hydrochloride | ONO PHARMACEUTICAL CO | 2014-07-30 | — | — | CN | disclosed |
| CN-101801931-B | Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors | ALMIRALL SA | 2014-05-14 | — | — | CN | disclosed |
| CN-102846474-B | Device and method for preparing vesica with inner and outer water phase gradient difference | UNIV SHENYANG PHARMACEUTICAL | 2014-04-09 | — | — | CN | disclosed |
| CN-103097353-A | Novel immunomodulator and anti-inflammatory compounds | INCOZEN THERAPEUTICS PVT LTD | 2013-05-08 | — | — | CN | disclosed |
| CN-1062735-C | Application of diphosphoric acid derivative in preparation of medicine for promoting bone repair | SANOFI ELF (FR) | 2001-03-07 | — | — | CN | disclosed |
| CN-1275123-A | Prostaglandin agonists and their use to treat bone disorders | PFIZER (US) | 2000-11-29 | — | — | CN | disclosed |
| EP-0998934-A1 | REMEDIES FOR INTRAMEDULLARY DISEASES | TORAY INDUSTRIES, INC. (JP) | 2000-05-10 | — | — | EP | disclosed |
| CN-1241176-A | Prevention of loss and restoration of bone mass by certain prostaglandin agonists | PFIZER (US) | 2000-01-12 | — | — | CN | disclosed |
| US-5739381-A | HEATING AQUEOUS SOLUTION OF DISODIUM TILUDRONATE HEMIHYDRATE, COOLING, FILTRATION OF FORMED MONOHYDRATE PRECIPITATE, DRYING | SANOFI (FR) | 1998-04-14 | — | — | US | disclosed |
| EP-0831789-A1 | STABLE PHARMACEUTICAL COMPOSITIONS CONTAINING TILUDRONATE HYDRATES AND PROCESS FOR PRODUCING THE PHARMACEUTICAL COMPOSITIONS | SANOFI (FR) | 1998-04-01 | — | — | EP | disclosed |
| US-5656288-A | SUBJECTING DISODIUM TILUDRONATE MONOHYDRATE TO AN EXCESS OF WATER TO OBTAIN DISODIUM TILUDRONATE TETRAHYDRATE; COMPOUNDING WITH SODIUM LAURYL SULFATE CARRIER | SANOFI WINTHROP, INC. (US) | 1997-08-12 | — | — | US | disclosed |
| WO-1996041618-A1 | STABLE PHARMACEUTICAL COMPOSITIONS CONTAINING TILUDRONATE HYDRATES AND PROCESS FOR PRODUCING THE PHARMACEUTICAL COMPOSITIONS | SANOFI (FR) | 1996-12-27 | — | — | WO | disclosed |
| CN-1104091-A | Application of diphosphoric acid derivative in preparation of medicine for promoting bone repair | SANOFI ELF (FR) | 1995-06-28 | — | — | CN | disclosed |
| US-5405994-A | Antiarthritic agents | SANOFI (FR) | 1995-04-11 | — | — | US | disclosed |